Boise, IDNCT03937154Now EnrollingIRB Ready

Chemotherapy-induced thrombocytopenia Clinical Trial in Boise, ID

Access cutting-edge chemotherapy-induced thrombocytopenia treatment through this clinical trial at a research site in Boise. Study-provided care at no cost to qualified participants.

Sponsored by Amgen

Quick Self-Assessment

See if you qualify for this Boise location

Preparing your pre-screening questions...

Expert Care in Boise

Access chemotherapy-induced thrombocytopenia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chemotherapy-induced thrombocytopenia treatment provided free

Apply for This Boise Location

Check if you qualify for this chemotherapy-induced thrombocytopenia clinical trial in Boise, ID

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boise

    Convenient for ID residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boise site if eligible
  4. 4Begin participation

About This Chemotherapy-induced thrombocytopenia Study in Boise

To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the ability to administer on-time, full-dose chemotherapy

Sponsor: Amgen

Who Can Participate

Inclusion Criteria

Subject has provided informed consent prior to initiation of any study-specific activities/procedures or subject's legally acceptable representative has provided informed consent prior to any study-specific activities/procedures being initiated when the subject has any kind of condition that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent.
Males or females greater than or equal to 18 years of age at signing of the informed consent.
Documented active stage I, II, III or IV locally advanced or metastatic of the following tumor types: NSCLC, breast cancer, or ovarian cancer (includes fallopian tube epithelial carcinomas and peritoneal epithelial carcinoma of unknown primary), or any stage recurrent disease. Patients with documented locally advanced (stage III) NSCLC should not be amenable to definitive treatment with chemoradiation and/or surgery.
Subjects must be receiving cancer treatment with 2

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boise?

Yes, this clinical trial (NCT03937154) has an active research site in Boise, ID that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chemotherapy-induced thrombocytopenia Treatment Options in Boise, ID

If you're searching for chemotherapy-induced thrombocytopenia treatment options in Boise, ID, this clinical trial (NCT03937154) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boise research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chemotherapy-induced thrombocytopenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chemotherapy-induced thrombocytopenia clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Boise, ID

See all pulmonary embolism clinical trials recruiting in Boise — not just this study.

Browse Pulmonary Embolism Trials in Boise →

Browse More Trials by Condition

Pulmonary Embolism TrialsRheumatoid Arthritis TrialsUlcerative Colitis TrialsErectile Dysfunction TrialsThrombocytopenia TrialsAll Conditions →

Ready to Join in Boise?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boise, ID